nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of function after limb salvage with non-invasive expandable or modular prostheses in children
|
Ness, Kirsten K. |
|
2014 |
50 |
18 |
p. 3212-3220 9 p. |
artikel |
2 |
An exploratory analysis of the factors leading to delays in cancer drug reimbursement in the European Union: The trastuzumab case
|
Ades, Felipe |
|
2014 |
50 |
18 |
p. 3089-3097 9 p. |
artikel |
3 |
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer
|
Hickish, Tamas |
|
2014 |
50 |
18 |
p. 3136-3144 9 p. |
artikel |
4 |
Assessing the impact of evolving evidence in renal cell carcinoma treatment: An update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)
|
Gore, M.E. |
|
2014 |
50 |
18 |
p. 3153-3160 8 p. |
artikel |
5 |
Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial
|
Ducreux, Michel |
|
2014 |
50 |
18 |
p. 3098-3106 9 p. |
artikel |
6 |
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) – A phase II non-randomised trial
|
Mitry, Emmanuel |
|
2014 |
50 |
18 |
p. 3107-3115 9 p. |
artikel |
7 |
First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials
|
Young, R.J. |
|
2014 |
50 |
18 |
p. 3178-3186 9 p. |
artikel |
8 |
Fixed-dose rate gemcitabine alone or alternating with FOLFIRI.3 (irinotecan, leucovorin and fluorouracil) in the first-line treatment of patients with metastatic pancreatic adenocarcinoma: An AGEO randomised phase II study (FIRGEM)
|
Trouilloud, Isabelle |
|
2014 |
50 |
18 |
p. 3116-3124 9 p. |
artikel |
9 |
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
|
Moehler, M. |
|
2014 |
50 |
18 |
p. 3125-3135 11 p. |
artikel |
10 |
Growth deceleration in children treated with imatinib for chronic myeloid leukaemia
|
Millot, Frédéric |
|
2014 |
50 |
18 |
p. 3206-3211 6 p. |
artikel |
11 |
Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index
|
van Spronsen, M.F. |
|
2014 |
50 |
18 |
p. 3198-3205 8 p. |
artikel |
12 |
Lipoprotein internalisation induced by oncogenic AMPK activation is essential to maintain glioblastoma cell growth
|
Ríos, M. |
|
2014 |
50 |
18 |
p. 3187-3197 11 p. |
artikel |
13 |
Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk
|
Llorca-Cardeñosa, Marta J. |
|
2014 |
50 |
18 |
p. 3168-3177 10 p. |
artikel |
14 |
No change in lymph node positivity rate despite increased lymph node yield and improved survival in colon cancer
|
van Erning, F.N. |
|
2014 |
50 |
18 |
p. 3221-3229 9 p. |
artikel |
15 |
Non-target progression – The fine line between objectivity and subjectivity
|
Lheureux, Stephanie |
|
2014 |
50 |
18 |
p. 3271-3272 2 p. |
artikel |
16 |
Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
|
Chen, Chi-An |
|
2014 |
50 |
18 |
p. 3161-3167 7 p. |
artikel |
17 |
Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomised phase 2 trial
|
Lam, S.W. |
|
2014 |
50 |
18 |
p. 3077-3088 12 p. |
artikel |
18 |
Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma
|
Milowsky, Matthew I. |
|
2014 |
50 |
18 |
p. 3145-3152 8 p. |
artikel |
19 |
PTEN/PIK3CA genes are frequently mutated in spontaneous and medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumours of tree shrews
|
Xia, Hou-Jun |
|
2014 |
50 |
18 |
p. 3230-3242 13 p. |
artikel |
20 |
Rapid adherence to collagen IV enriches for tumour initiating cells in oral cancer
|
Liang, Xiao |
|
2014 |
50 |
18 |
p. 3262-3270 9 p. |
artikel |
21 |
Synergism of arsenic trioxide and MG132 in Raji cells attained by targeting BNIP3, autophagy, and mitochondria with low doses of valproic acid and vincristine
|
Cavaliere, Victoria |
|
2014 |
50 |
18 |
p. 3243-3261 19 p. |
artikel |